These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16098628)

  • 1. Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis.
    Stärkel P; De Saeger C; Leclercq I; Strain A; Horsmans Y
    J Hepatol; 2005 Oct; 43(4):687-95. PubMed ID: 16098628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans.
    Stärkel P; Bishop K; Horsmans Y; Strain AJ
    Am J Pathol; 2003 Feb; 162(2):587-96. PubMed ID: 12547716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.
    Smith MW; Yue ZN; Korth MJ; Do HA; Boix L; Fausto N; Bruix J; Carithers RL; Katze MG
    Hepatology; 2003 Dec; 38(6):1458-67. PubMed ID: 14647057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem.
    Carey EJ; Balan V; Kremers WK; Hay JE
    Liver Transpl; 2003 Nov; 9(11):1166-73. PubMed ID: 14586877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
    Wu TT; Levy M; Correa AM; Rosen CB; Abraham SC
    Cancer; 2009 Oct; 115(19):4564-75. PubMed ID: 19670455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of signal transducer and activator of transcription 3 in liver fibrosis progression in chronic hepatitis C-infected patients.
    Stärkel P; Saeger CD; Leclercq I; Horsmans Y
    Lab Invest; 2007 Feb; 87(2):173-81. PubMed ID: 17318196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes.
    Basu A; Meyer K; Lai KK; Saito K; Di Bisceglie AM; Grosso LE; Ray RB; Ray R
    Virology; 2006 Jun; 349(2):347-58. PubMed ID: 16545852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].
    Gan L; Yin ZF; Li M
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):419-21. PubMed ID: 18581899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies.
    Spee B; Arends B; van den Ingh TS; Brinkhof B; Nederbragt H; Ijzer J; Roskams T; Penning LC; Rothuizen J
    Liver Int; 2006 Aug; 26(6):716-25. PubMed ID: 16842329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells.
    Yagil Z; Kay G; Nechushtan H; Razin E
    J Immunol; 2009 Feb; 182(4):2168-75. PubMed ID: 19201870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation.
    Wells JT; Said A; Agni R; Tome S; Hughes S; Dureja P; Lucey MR
    Liver Transpl; 2007 Dec; 13(12):1728-35. PubMed ID: 18044757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized morphometry of the cirrhotic liver: comparative analysis in primary biliary cirrhosis, alcoholic cirrhosis, and posthepatitic cirrhosis.
    Vertemati M; Minola E; Goffredi M; Sabatella G; Gambacorta M; Vizzotto L
    Microsc Res Tech; 2004 Oct; 65(3):113-21. PubMed ID: 15605407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis distribution in explanted cirrhotic livers.
    Hall A; Germani G; Isgrò G; Burroughs AK; Dhillon AP
    Histopathology; 2012 Jan; 60(2):270-7. PubMed ID: 22211285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological characteristics of HCV cirrhosis of the liver].
    Chirskiĭ VS; Zhdanov KV; Gusev DA; Alent'ev GA
    Arkh Patol; 2009; 71(6):29-32. PubMed ID: 20131503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.